Tofacitinib Citrate CAS 540737-29-9

Tofacitinib Citrate CAS 540737-29-9

Details
Tofacitinib Citrate CAS 540737-29-9, is a Janus kinase (JAK) inhibitor that is administered orally and has immunomodulatory and anti-inflammatory effects. It is a citrate formed by combining tofacitinib with citric acid in an equimolar ratio.
Indications: Rheumatoid arthritis (RA), Psoriatic arthritis (PsA), Ankylosing spondylitis (AS)
Category
API
Share to
Send Inquiry
Description
Technical Parameters

Zhejiang Hengkang Pharmaceutical Co., Ltd. is one of the most reliable manufacturers and suppliers of tofacitinib citrate cas 540737-29-9 in China, featured by quality products and good service. Please rest assured to wholesale bulk tofacitinib citrate cas 540737-29-9 made in China here from our factory.

 

Product Introduction

 

  • Tofacitinib Citrate

Tofacitinib Citrate CAS 540737-29-9

product-275-138

Chemical Name

1-PIPERIDINEPROPANENITRILE,4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-,(3R,4R)-,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE(1:1)

Quanlity standard

IH

Regulatory documentation

N/A

Packing size

25kg/drum

Storage condition

Not more than 30℃

 

Hot Tags: tofacitinib citrate cas 540737-29-9, China tofacitinib citrate cas 540737-29-9 manufacturers, suppliers, factory, 103177-37-3, 123663-49-0, Acalabrutinib, CAS 89 57 6, Ciprofibrate, Lemborexant

Send Inquiry
CDMOSERVICES

Dedicated to new drug R&D and the production of APIs and intermediates.

Contact now!